LINEAGE CELL THERAPEUTICS IN
LCTX·53566P109·US·Common Stock·Healthcare - Biotechnology-Activist
LCTX (LINEAGE CELL THERAPEUTICS IN) is held by 79 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($17.3M), VANGUARD CAPITAL MANAGEMENT LLC ($11.9M), GEODE CAPITAL MANAGEMENT, LLC ($6.9M). Net institutional sentiment: Mixed.
79
Holders
(8 Elite)
$69.7M
Total Value
55% (82)
Consensus
45 buying - 37 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 19, 2026 · Insiders Mar 12, 2026 · Activists Jul 29, 2026 · Congress none
InsiderCMCulley Brian MBuy $24KMar 12, 2026
InsiderCMCulley Brian MVest 9K shDec 19, 2025
Checking access…
Top Holders
Checking access…
Showing 1-20 of 95
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer